Two groups of patients with delusional illnesses (previous paranoics and previous ‘late schizophrenics’ with delusional syndromes) with similar backgrounds, were followed up after many years and were re-examined in the same way. They were compared with each other as regards further developments of delusional formations and their psycho-pathological determinants. In the group of ‘late schizophrenics’ the delusions disappeared more frequently than in the groups of paranoics, and the delusional productivity diminished more often. On examination of various psychopathological characteristics and their influence on the further development of delusional formations (core syndromes of the general psychiatric symptomatology, appearance of affective changes, further development of the delusional productivity) only tendencies are shown, never obligatory relationships. The order of the relationships which we found remains uncertain; it is not likely that we are dealing with relationships of the first order.

This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.